Join to view full profile
2100 Erwin RdDurham, NC 27705
Phone+1 919-620-4467
Dr. Long is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Stanford Health Care-Sponsored Stanford UniversityFellowship, Medical Oncology, 1987 - 1990
Vanderbilt University Medical CenterResidency, Internal Medicine, 1983 - 1986
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 1983
Certifications & Licensure
CA State Medical License 1987 - Present
NC State Medical License 1996 - 2027
VA State Medical License 2003 - 2006
TN State Medical License 1984 - 1987
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2013-2014, 2016-2017
- CMS Meaningful Use Stage 2 Certification Beacon Oncology 2014 Certified Module, Epic Systems Corporation, 2013-2014, 2016-2017
Clinical Trials
- Sirolimus/Tacrolimus Versus Tacrolimus/Methotrexate for Preventing Graft-Versus-Host Disease (GVHD) (BMT CTN 0402)
- Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403)
- Trial of CMV Specific DLIs From 3-6/6 HLA Matched Family Member Following Nonmyeloablative Allo SCT
Publications & Presentations
PubMed
- Sociodemographic factors and timing of allogeneic hematopoietic stem cell transplantation in myeloproliferative neoplasms.Allison O Taylor, Joshua S Mercer, Claire I Bradbury, Samantha M Thomas, Edwin Alyea 3rd
Bone Marrow Transplantation. 2026-06-01 - Impact of donor age on cognitive recovery in allogenic hematopoietic stem cell transplant patients with mild cognitive impairment.Matthew A Bergens, Matthew Braun, Ernaya J Johnson, Yan Li, Jamie S Myers
Bone Marrow Transplantation. 2026-06-01 - Musculoskeletal Adverse Events Following BCMA CAR T-Cell Therapy in Multiple Myeloma: Clinical Characteristics and Immune Correlates.Amber Feng, Jian Wu, Taewoong Choi, Xiaobei Wang, Tanya Bellavia
Transplantation and Cellular Therapy. 2026-05-01
Abstracts/Posters
- Decreased Mortality after the First Year of Allogeneic Hematopoietic Stem Cell Transplant in Recipients of Umbilical Cord Blood Vs. Matched Related or Matched Unrelate...Gwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Evaluation of the Oral SYK Inhibitor Fostamatinib in Patients after Allogeneic Transplantation for Chronic Graft-Versus-Host DiseaseGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Geriatric Assessment Identifies Impairments in Younger Candidates for Allogeneic Hematopoietic Stem Cell TransplantationGwynn D. Long, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
